US Stock MarketDetailed Quotes
MRNA Moderna
- 125.590
- +14.130+12.68%
Close May 2 16:00 ET
- 123.895
- -1.695-1.35%
Post 19:22 ET
48.09BMarket Cap-8055P/E (TTM)
128.810High114.060Low11.97MVolume114.860Open111.460Pre Close1.47BTurnover3.43%Turnover RatioLossP/E (Static)382.88MShares142.79052wk High3.75P/B43.85BFloat Cap62.55052wk Low--Dividend TTM349.18MShs Float497.490Historical High--Div YieldTTM13.23%Amplitude11.540Historical Low122.462Avg Price1Lot Size
Moderna Stock Forum
Sign in to post a comment
ColumnsToday's Morning Movers and Top Ratings: CVNA, QCOM, PTON, MRNA and More
Morning Movers
Gapping up
$Carvana(CVNA.US$ soared by 35% following the company's unexpected prediction of an increase in retail sales and fundamental earnings for the current quarter, driven by consumers gravitating towards pre-owned vehicles due to rising interest rates.
$Qualcomm(QCOM.US$ climbed 5.6% after the semiconductor manufacturer projected sales and adjusted earnings for the quarter that exceeded forecasts, spu...
Gapping up
$Carvana(CVNA.US$ soared by 35% following the company's unexpected prediction of an increase in retail sales and fundamental earnings for the current quarter, driven by consumers gravitating towards pre-owned vehicles due to rising interest rates.
$Qualcomm(QCOM.US$ climbed 5.6% after the semiconductor manufacturer projected sales and adjusted earnings for the quarter that exceeded forecasts, spu...
27
1
🔔 FDA PDUFA Update…
📣 3 PDUFAs left in April! See summary 👇
🗓️ Last week’s PDUFAs:
$Pfizer(PFE.US$ : Approved 4/26 🎉
⇨ BEQVEZ (fidanacogene elaparvovec-dzkt)
▹ Hemophilia B
▹ BLA
▹ PDUFA date: Q2 2024
$Day One Biopharmaceuticals(DAWN.US$ : Approved 4/23 🎉
⇨ OJEMDA (tovorafenib)
▹ Pediatric low-grade glioma
▹ NDA
▹ PDUFA date: 4/30/24
$ImmunityBio(IBRX.US$ : Approved 4/22 🎉
⇨ Anktiva + BCG
▹ Bladder cancer
▹ resubmitted BLA
▹ PDUFA date: 4/23/24
$Abeona Therapeutics(ABEO.US$ : CRL 4/22 🙁
⚠...
🗓️ Last week’s PDUFAs:
$Pfizer(PFE.US$ : Approved 4/26 🎉
⇨ BEQVEZ (fidanacogene elaparvovec-dzkt)
▹ Hemophilia B
▹ BLA
▹ PDUFA date: Q2 2024
$Day One Biopharmaceuticals(DAWN.US$ : Approved 4/23 🎉
⇨ OJEMDA (tovorafenib)
▹ Pediatric low-grade glioma
▹ NDA
▹ PDUFA date: 4/30/24
$ImmunityBio(IBRX.US$ : Approved 4/22 🎉
⇨ Anktiva + BCG
▹ Bladder cancer
▹ resubmitted BLA
▹ PDUFA date: 4/23/24
$Abeona Therapeutics(ABEO.US$ : CRL 4/22 🙁
⚠...
11
2
$Moderna(MRNA.US$ can it break 115? insider is selling though
I ain't sell anything yet. in waiting for everything to soar before I sell$Moderna(MRNA.US$ can you go up 1 day, i beg you
2
so weak
Novavax to Supply Updated COVID-19 Vaccine to Private Healthcare Providers in the United Kingdom
$Novavax(NVAX.US$$Moderna(MRNA.US$
April 18, 2024
For Global Investor Audience Only
Novavax’s Nuvaxovid XBB.1.5 dispersion for injection, COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2601) is now available to pharmacies across the United Kingdom (U.K.) for private healthcare providers to offer an updated protein-based non-mRNA option as part of the 2024 vaccination season.
To...
April 18, 2024
For Global Investor Audience Only
Novavax’s Nuvaxovid XBB.1.5 dispersion for injection, COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2601) is now available to pharmacies across the United Kingdom (U.K.) for private healthcare providers to offer an updated protein-based non-mRNA option as part of the 2024 vaccination season.
To...
1
ESPR is the Probably the Most Undervalued Stock on the Market, Offers 2500% Upside. 2 FDA Approved Blockbuster Drugs. Billions in Sales Expected. Buyout Expected.
$Esperion Therapeutics(ESPR.US$ Esperion (ESPR) stock price has dropped from a recent high of $3.40 a share to $2.31 on FALSE claims of dilution. The price drop offers an amazing buying opportunity.
Huge News On Mar 25.2024 U.S. FDA Approved Broad Labels for NEXLIZET and NEXLETOL, now regular doctors can prescribe and Insurance will...
Huge News On Mar 25.2024 U.S. FDA Approved Broad Labels for NEXLIZET and NEXLETOL, now regular doctors can prescribe and Insurance will...
3
ColumnsToday's Morning Movers and Top Ratings: DAL, MRNA, ALB and More
Morning Movers
Gapping up
$Delta Air Lines(DAL.US$ stock rose 4.3% following the airline's optimistic outlook for the current quarter, bolstered by strong travel demand that led to first-quarter earnings surpassing estimates.
$Moderna(MRNA.US$ stock increased by 0.6%, building on the previous session's 6% gain, after the company released promising cancer-vaccine data, indicating potential effectiveness beyond just melanoma.
$Taiwan Semiconductor(TSM.US$ stock gr...
Gapping up
$Delta Air Lines(DAL.US$ stock rose 4.3% following the airline's optimistic outlook for the current quarter, bolstered by strong travel demand that led to first-quarter earnings surpassing estimates.
$Moderna(MRNA.US$ stock increased by 0.6%, building on the previous session's 6% gain, after the company released promising cancer-vaccine data, indicating potential effectiveness beyond just melanoma.
$Taiwan Semiconductor(TSM.US$ stock gr...
20
FDA PDUFA Update…
🗓️ Last week’s PDUFAs:
$Supernus Pharmaceuticals(SUPN.US$ : CRL 4/8/24 🙁
⇒ SPN-830
⇒ OFF episodes in PD
⇒ NDA
⇒ PDUFA: 4/5/24
$Legend Biotech(LEGN.US$ & $Johnson & Johnson(JNJ.US$ : Approved 🎉
⇒ CARVYKTI (cilta-cel)
⇒ Multiple myeloma
⇒ sBLA
⇒ PDUFA: 4/5/24
$AstraZeneca(AZN.US$ : Approved 🎉
⇒ Enhertu
⇒ HER2+ solid tumors
⇒ sBLA
⇒ PDUFA: Q2 2024
$2seventy bio(TSVT.US$ & $Bristol-Myers Squibb(BMY.US$ : Approved 🎉
⇒ Abecma
⇒ Multiple myeloma
⇒ sBLA
⇒ Delayed PDUFA
$Vanda Pharmaceuticals(VNDA.US$...
$Supernus Pharmaceuticals(SUPN.US$ : CRL 4/8/24 🙁
⇒ SPN-830
⇒ OFF episodes in PD
⇒ NDA
⇒ PDUFA: 4/5/24
$Legend Biotech(LEGN.US$ & $Johnson & Johnson(JNJ.US$ : Approved 🎉
⇒ CARVYKTI (cilta-cel)
⇒ Multiple myeloma
⇒ sBLA
⇒ PDUFA: 4/5/24
$AstraZeneca(AZN.US$ : Approved 🎉
⇒ Enhertu
⇒ HER2+ solid tumors
⇒ sBLA
⇒ PDUFA: Q2 2024
$2seventy bio(TSVT.US$ & $Bristol-Myers Squibb(BMY.US$ : Approved 🎉
⇒ Abecma
⇒ Multiple myeloma
⇒ sBLA
⇒ Delayed PDUFA
$Vanda Pharmaceuticals(VNDA.US$...
11
2
$Moderna(MRNA.US$ dang I've been watching this lately for some reason wish I knew
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Apit55 : $NVIDIA (NVDA.US)$